(CNS): The world’s eyes and ears are expectantly focussed on the forthcoming first-ever UN High Level Meeting (UNHLM) to #endTB: “United to End TB: An Urgent Global Response to a Global Epidemic.” The global TB community is hailing this as a landmark opportunity to marshal political will and resources to end TB by 2030. Will this meeting actually turn out to be the magic potion that would rid the world of TB by 2030?
“This is an unprecedented opportunity when for the first time ever, over 45 heads of State will actually make statements of commitments to end TB at this event, at the 73rd UN General Assembly (UNGA). It is hopefully going to be a turning point in the fight against TB”, said Dr Soumya Swaminathan, Deputy Director General for Programmes, World Health Organization (WHO), in an exclusive interview given to CNS (Citizen News Service).
Dr Soumya Swaminathan further said that it is also proposed to have a national accountability mechanism for every head of State to commit and be accountable for progress on TB. Moreover the meeting will hopefully help to mobilize more funding: both for TB programmes and for TB research and innovation – particularly for more domestic resources from middle-income countries and from the high TB burden countries. The event will also create a huge amount of awareness bringing together civil society, patient voices, political commitment as well as the experts on TB and translate into concrete actions at country level in order to achieve the global goals.
Dr KS Sachdeva, who heads the national TB programme of India as Deputy Director General of Central TB Division, Ministry of Health and Family Welfare, Government of India, calls the meeting a welcome step to put TB on the high level agenda of UNGA and give it the much deserved attention. He is optimistic that it will force the high-level politicians and others who have the power to make health as a development agenda, to realise that TB is one disease whose elimination can move us towards achieving the sustainable development goals. Tackling TB can actually contribute to reduction in poverty, being airborne, TB is one disease which anybody can get. So, making developing countries TB free is actually in the interest of all the countries of the world, he told CNS (Citizen News Service).
Some chilling facts
The meeting does come at a time which we can call turbulent, in terms of TB control. WHO’s latest Global TB Report released last week, does not paint a very bright picture of the status of the TB epidemic. The year 2017 saw an estimated 10 million people developing TB and 1.6 million TB related deaths globally. The number of new cases is falling by 2% per year, which is much too slow to achieve the desired annual decrease of 10% by 2025 if we are to remain on track to end TB by 2030.
Under-reporting and under-diagnosis of TB cases remains a major challenge. Current treatment coverage is 64% (of those who fell ill with TB) and must increase to at least 90% by 2025 to meet the TB targets. Of the estimated 558000 people who developed multidrug-resistant TB (MDR-TB) or rifampicin resistant TB (RR-TB) in 2017, only 25% people were enrolled on treatment with a second-line regimen. Globally, MDR-TB treatment success remains low at 55%. The report also flags that, unless scaled up drastically, the annual gap in funding for TB prevention and care in low- and middle-income countries is likely to widen to US$ 5.4 billion by 2020 from the current US$ 3.5 billion.
Close the funding gap
TB Alliance (Global Alliance for TB Drug Development) has called upon all countries to “step up the fight to defeat TB and overcome antimicrobial resistance (AMR) by closing the funding gap for TB research and product development through equitable approaches, securing universal access to new medicines and fostering global collaboration.”
TB Alliance strongly endorses five key asks as priority actions which Heads of State and governments must take:
- Reach all people by closing the gaps on TB diagnosis, treatment, and prevention and have appropriate simple, short and effective TB treatment available to all;
Transform the TB response to be equitable and rights based;
Accelerate development of essential new tools to end TB;
Invest the funds necessary to End TB; and
Commit to decisive and accountable global leadership, including regular UN reporting and review
Civil society voices
Medicins Sans Frontieres (MSF, or Doctors Without Borders) too has joined numerous patient and civil society organisations in calling for the attendance of governments and heads of States at the UNHLM and:
- Declare ambitious national targets to close the gaps in testing, treatment and prevention;
Mobilize their scientific communities and increase funding for TB research and development;
Ensure equitable and affordable access to all TB medicines and medical products for all who need them, including overcoming patent barriers as allowed through flexibilities in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property (TRIPS); and
Institute an accountability framework that ensures all governments are on track and held accountable to meeting their stated national and global commitments.
WHO has called for an unprecedented mobilization of national and international commitments, and urged political leaders to take decisive action. “We have never seen such high-level political attention and understanding of what the world needs to do to end TB and drug-resistant TB. We must capitalize on this new momentum and act together to end this terrible disease” said Dr Tedros Adhanom Ghebreyesus, WHO Director General.
Are we really committed?
All these are noble and laudable intentions, but unless matched by appropriate and continued sustainable action, it will remain a rhetoric. Ending the TB epidemic requires action beyond the health sector to address the risk factors and determinants of the disease. History seems to be repeating itself at this so-called historic summit. Despite WHO’s best efforts, its Global Ministerial Conference “Ending TB in the Sustainable Development Era: A Multi-sectoral Response” held in Moscow in November 2017, had managed to attract only the Health Ministers, barring a few exceptions.
Politics is the ultimate determinant of health
Similarly less than 50 odd heads of States seem to have deemed the UNHLM to end TB important enough to merit their presence. All others (including India which accounts for the highest TB burden worldwide) will be content to be represented by their ministers of health and/or other high officials. So how can one expect to galvanise a global multi-sectoral action, when the highest political authorities of most countries do not think it important enough to be present at a meeting convened for them? Unless countries deliver on the SDGs, which requires coordinated and concerted interdepartmental efforts at country level, we will not be able to end TB. Merely issuing declarations will not do! It is not about “We can” but that “We will.” It is about political accountability. Let us remember what Chief Editor of The Lancet Dr Richard Horton said: “Politics is, in many ways, the ultimate determinant of our health.” Hope world leaders commit to put TB response on track to end TB by 2030!
Shobha Shukla, CNS (Citizen News Service)
(Shobha Shukla is the Managing Editor at CNS (Citizen News Service). Follow her on Twitter @Shobha1Shukla, @CNS_Health or visit www.citizen-news.org)
- Shared under Creative Commons (CC) Attribution License